Among 29 NSCLC patients with oligometastases without EGFR-targetable or ALK-targetable mutation who finished induction chemotherapy, 14 had SBRT and maintenance chemotherapy, and 15 had maintenance chemotherapy only. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.